Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hookipa Pharma
AddedFeb 19, 2024
UpdatedJun 18, 2026
Hookipa Pharma

Hookipa Pharma

Public

NYC-based Hookipa pioneers in developing superior immunization therapies for infections and cancer.

HQ
New York City, NY, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in New York City, Hookipa Pharma is a clinical-stage biotech company dedicated to developing advanced immunization therapies for infectious diseases and oncology. Their core mission is to harness the power of the immune system to create best-in-class treatments that offer superior efficacy and safety. Hookipa's innovative approach focuses on leveraging CD8+ T cells to target and destroy cancer cells, as well as combat infectious pathogens. The company aims to revolutionize the landscape of immunotherapy through its cutting-edge research and development.

Hookipa Pharma has garnered attention from notable investors and industry leaders, contributing to its rapid growth and recognition in the biotech sector. The company's key achievements include presenting positive clinical data at prestigious conferences such as the American Society of Clinical Oncology. These milestones underscore Hookipa's potential to make significant impacts in the fields of infectious disease and cancer treatment. Through their pioneering work, Hookipa Pharma is poised to transform immunotherapy, offering new hope to patients worldwide.

Hookipa Pharma - Similar Companies

Immunome logo

Immunome

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

INmune Bio logo

INmune Bio

inmunebio.com

Immunophotonics logo

Immunophotonics

Umoja Biopharma logo

Umoja Biopharma

Photonpharma logo

Photonpharma

photonpharma.net

Nantkwest logo

Nantkwest

OncoPep logo

OncoPep

oncopep.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

ImmunityBio logo

ImmunityBio

immunitybio.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

NextCure logo

NextCure

nextcure.com

HI-Bio logo

HI-Bio

hibio.com

Cleveland BioLabs logo

Cleveland BioLabs

NightHawk Biosciences logo

NightHawk Biosciences

Hookipa Pharma - Quick Facts

Who are Hookipa Pharma's competitors?

Companies similar to Hookipa Pharma include Immunome, Novita Pharmaceuticals, INmune Bio and Immunophotonics.

When was Hookipa Pharma founded?

Hookipa Pharma was founded in 2011.

Where is Hookipa Pharma's headquarters located?

Hookipa Pharma's headquarters is located in New York City, NY, US.

When was Hookipa Pharma's last funding round?

Hookipa Pharma's most recent funding round was for $21.3M (USD) in December 2023.

How much has Hookipa Pharma raised to-date?

As of Dec 21, 2023, Hookipa Pharma has raised a total of $284.8M (USD).

How many employees does Hookipa Pharma have?

Hookipa Pharma has 136 employees as of Feb 6, 2024.

Hookipa Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
  • Immunotherapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research